DL-Homocystine
CAS No. 462-10-2
DL-Homocystine( —— )
Catalog No. M20027 CAS No. 462-10-2
Homocystine is the double-bonded form of homocysteine but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfide account for >98% of total homocysteine in plasma from healthy individuals.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameDL-Homocystine
-
NoteResearch use only, not for human use.
-
Brief DescriptionHomocystine is the double-bonded form of homocysteine but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfide account for >98% of total homocysteine in plasma from healthy individuals.
-
DescriptionHomocystine is the double-bonded form of homocysteine but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfide account for >98% of total homocysteine in plasma from healthy individuals.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number462-10-2
-
Formula Weight268.35
-
Molecular FormulaC8H16N2O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: Soluble;Water: Soluble
-
SMILESNC(CCSSCCC(N)C(O)=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sengupta S et al. Relative roles of albumin and ceruloplasmin in the formation of homocystine homocysteine-cysteine-mixed disulfide and cystine in circulation. J Biol Chem. 2001 Dec 14;276(50):46896-904.
molnova catalog
related products
-
kuwanon G
Kuwanon G as dual inhibitors of PTP1B and α-glucosidase enzymes, as well as insulin sensitizers, it may potentially be utilized as an effective treatment for Type II diabetes mellitus.
-
JNJ-26990990
JNJ-26990990 is a broad-spectrum anticonvulsant drug as a second-generation followup to the marketed drug topiramate.
-
MP265
MP265 disrupts the MreB cytoskeleton and has antiproliferative effects.
Cart
sales@molnova.com